OGEN | tickerfilter.com

Fundamental analysis

22%

Profitability 25%

Dept financing 5%

Liquidity 50%

Performance 16%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

24.51%

1 Month

20.95%

3 Months

-37.75%

6 Months

-10.56%

1 Year

-57.45%

2 Year

-93.19%

Key data

Stock price

$1.27

P/E Ratio

0.00

DAY RANGE

$1.11 - $1.29

EPS

$0.00

52 WEEK RANGE

$0.86 - $7.74

52 WEEK CHANGE

-$0.63

MARKET CAP

7.087 M

YIELD

N/A

SHARES OUTSTANDING

5.581 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

1.45

PUBLIC FLOAT

AVERAGE 10 VOLUME

$590,221

AVERAGE 30 VOLUME

$1,586,509

Company detail

CEO:
Region: US
Website: https://www.oragenics.com/
Employees: 18
IPO year: -

Issue type: Common Stock
Market: NYSE American
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

oragenics is a publicly-traded biopharmaceutical company with a pipeline of unique proprietary technologies. offerings are based on the probiora3 technology and brands include evoraplus™ is a new, one-of-a-kind probiotic mint that naturally supports gum and tooth health while freshening breath and whitening teeth. oragenics has a number of products in discovery, preclinical and clinical development, with a concentration in the main therapeutic area of infectious diseases, in diagnostics, and in oral health.

OGEN - Oragenics Inc